Titre : Cinéangiographie

Cinéangiographie : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cinéangiographie : Questions médicales les plus fréquentes", "headline": "Cinéangiographie : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cinéangiographie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-28", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cinéangiographie" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Angiographie", "url": "https://questionsmedicales.fr/mesh/D000792", "about": { "@type": "MedicalCondition", "name": "Angiographie", "code": { "@type": "MedicalCode", "code": "D000792", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E01.370.370.050" } } }, "about": { "@type": "MedicalCondition", "name": "Cinéangiographie", "alternateName": "Cineangiography", "code": { "@type": "MedicalCode", "code": "D002932", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Stefano Molinaro", "url": "https://questionsmedicales.fr/author/Stefano%20Molinaro", "affiliation": { "@type": "Organization", "name": "Interventional Neuroradiology, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy stefanomolinaro52@gmail.com." } }, { "@type": "Person", "name": "Francesco Mistretta", "url": "https://questionsmedicales.fr/author/Francesco%20Mistretta", "affiliation": { "@type": "Organization", "name": "Department of Surgical Sciences, Università degli Studi di Torino, Torino, Italy." } }, { "@type": "Person", "name": "Riccardo Russo", "url": "https://questionsmedicales.fr/author/Riccardo%20Russo", "affiliation": { "@type": "Organization", "name": "Surgical Science, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino, Torino, Italy." } }, { "@type": "Person", "name": "Gaetano Risi", "url": "https://questionsmedicales.fr/author/Gaetano%20Risi", "affiliation": { "@type": "Organization", "name": "Radiology, Università degli Studi di Torino, Torino, Italy." } }, { "@type": "Person", "name": "Fabrizio Venturi", "url": "https://questionsmedicales.fr/author/Fabrizio%20Venturi", "affiliation": { "@type": "Organization", "name": "Neuroradiology, Azienda Ospedaliera S Croce e Carle Cuneo, Cuneo, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36086927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocd.15375" } }, { "@type": "ScholarlyArticle", "name": "ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36600424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-067251" } }, { "@type": "ScholarlyArticle", "name": "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35617986", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2213-2600(22)00088-1" } }, { "@type": "ScholarlyArticle", "name": "Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.", "datePublished": "2024-08-14", "url": "https://questionsmedicales.fr/article/39161682", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/DDDT.S472651" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36612875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20010552" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Diagnostic", "item": "https://questionsmedicales.fr/mesh/D003933" }, { "@type": "ListItem", "position": 3, "name": "Techniques et procédures diagnostiques", "item": "https://questionsmedicales.fr/mesh/D019937" }, { "@type": "ListItem", "position": 4, "name": "Techniques de diagnostic cardiovasculaire", "item": "https://questionsmedicales.fr/mesh/D003935" }, { "@type": "ListItem", "position": 5, "name": "Angiographie", "item": "https://questionsmedicales.fr/mesh/D000792" }, { "@type": "ListItem", "position": 6, "name": "Cinéangiographie", "item": "https://questionsmedicales.fr/mesh/D002932" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cinéangiographie - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cinéangiographie", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-01", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cinéangiographie", "description": "Quand utilise-t-on la cinéangiographie ?\nQuels examens précèdent la cinéangiographie ?\nLa cinéangiographie est-elle invasive ?\nQuels sont les risques de la cinéangiographie ?\nComment se déroule une cinéangiographie ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cinéangiographie", "description": "Quels symptômes indiquent une angiopathie ?\nComment reconnaître une obstruction vasculaire ?\nQuels signes d'alerte nécessitent une cinéangiographie ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes d'une thrombose sont-ils spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cinéangiographie", "description": "Comment prévenir les maladies vasculaires ?\nLe tabagisme influence-t-il la santé vasculaire ?\nLe contrôle du diabète est-il important ?\nL'hypertension peut-elle être évitée ?\nLes bilans de santé réguliers sont-ils utiles ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cinéangiographie", "description": "Quels traitements suivent une cinéangiographie ?\nLa cinéangiographie peut-elle être thérapeutique ?\nQuels médicaments sont souvent prescrits après ?\nLa réhabilitation est-elle nécessaire après ?\nQuels sont les soins post-procédure ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cinéangiographie", "description": "Quelles complications peuvent survenir après la cinéangiographie ?\nComment gérer une réaction allergique ?\nLes complications sont-elles fréquentes ?\nQuels signes indiquent une complication grave ?\nLa surveillance post-procédure est-elle nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cinéangiographie", "description": "Quels sont les principaux facteurs de risque vasculaires ?\nL'hérédité joue-t-elle un rôle ?\nLe stress influence-t-il la santé vasculaire ?\nL'âge est-il un facteur de risque ?\nL'alimentation impacte-t-elle la santé vasculaire ?", "url": "https://questionsmedicales.fr/mesh/D002932?mesh_terms=Double-Blind+Method&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quand utilise-t-on la cinéangiographie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée pour évaluer les maladies vasculaires et les anomalies circulatoires." } }, { "@type": "Question", "name": "Quels examens précèdent la cinéangiographie ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des examens comme l'échographie ou l'IRM peuvent être réalisés pour évaluer l'état vasculaire." } }, { "@type": "Question", "name": "La cinéangiographie est-elle invasive ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle nécessite l'insertion d'un cathéter pour administrer l'agent de contraste." } }, { "@type": "Question", "name": "Quels sont les risques de la cinéangiographie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des réactions allergiques à l'agent de contraste et des saignements." } }, { "@type": "Question", "name": "Comment se déroule une cinéangiographie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le patient est allongé, un cathéter est inséré, et des images sont prises pendant l'injection." } }, { "@type": "Question", "name": "Quels symptômes indiquent une angiopathie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs, engourdissements, ou faiblesse dans les membres peuvent indiquer une angiopathie." } }, { "@type": "Question", "name": "Comment reconnaître une obstruction vasculaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur thoracique, essoufflement ou fatigue excessive lors d'efforts." } }, { "@type": "Question", "name": "Quels signes d'alerte nécessitent une cinéangiographie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes, des changements de couleur de la peau ou des ulcères peuvent alerter." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées, nécessitant une attention accrue." } }, { "@type": "Question", "name": "Les symptômes d'une thrombose sont-ils spécifiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Non, ils peuvent être similaires à d'autres conditions, rendant le diagnostic difficile." } }, { "@type": "Question", "name": "Comment prévenir les maladies vasculaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, avec une alimentation équilibrée et de l'exercice régulier." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la santé vasculaire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de maladies vasculaires et d'obstructions." } }, { "@type": "Question", "name": "Le contrôle du diabète est-il important ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un bon contrôle du diabète aide à prévenir les complications vasculaires." } }, { "@type": "Question", "name": "L'hypertension peut-elle être évitée ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut être gérée par des changements de mode de vie et des médicaments si nécessaire." } }, { "@type": "Question", "name": "Les bilans de santé réguliers sont-ils utiles ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des problèmes vasculaires et d'agir rapidement." } }, { "@type": "Question", "name": "Quels traitements suivent une cinéangiographie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des médicaments, une angioplastie ou une chirurgie selon les résultats." } }, { "@type": "Question", "name": "La cinéangiographie peut-elle être thérapeutique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour traiter certaines conditions, comme la dilatation des vaisseaux." } }, { "@type": "Question", "name": "Quels médicaments sont souvent prescrits après ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des anticoagulants ou des antiplaquettaires sont souvent prescrits pour prévenir les complications." } }, { "@type": "Question", "name": "La réhabilitation est-elle nécessaire après ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une réhabilitation peut être recommandée pour améliorer la circulation et la fonction vasculaire." } }, { "@type": "Question", "name": "Quels sont les soins post-procédure ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Surveillance des signes vitaux, gestion de la douleur et observation du site d'insertion sont essentiels." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après la cinéangiographie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des saignements, des infections ou des réactions à l'agent de contraste." } }, { "@type": "Question", "name": "Comment gérer une réaction allergique ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Il est crucial d'informer le personnel médical immédiatement pour un traitement approprié." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont rares, mais le risque augmente avec des antécédents médicaux complexes." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs intenses, des saignements excessifs ou des signes d'infection doivent alerter." } }, { "@type": "Question", "name": "La surveillance post-procédure est-elle nécessaire ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance est essentielle pour détecter rapidement toute complication éventuelle." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque vasculaires ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension, le diabète, le tabagisme et l'obésité sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque individuel." } }, { "@type": "Question", "name": "Le stress influence-t-il la santé vasculaire ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à des problèmes vasculaires et cardiaques." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de maladies vasculaires augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "L'alimentation impacte-t-elle la santé vasculaire ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées et en sucres augmente le risque vasculaire." } } ] } ] }

Sources (10000 au total)

Evaluating the effectiveness of stromal-vascular fraction (SVF) cells along with subcision method in the treatment of acne scars: A double-blind randomized controlled clinical trial study.

Subcision method is one of the main techniques for treatment of acne scars or stromal-vascular fraction (SVF) and combined therapy can improve treatment strategy.... To use subcision method along with SVF for treatment of acne scar and comprised with alone subcision method.... In this double-blind clinical trial study, 10 patients with acne scars were entered into the study. Subcision technique was randomly performed on one side of the face and subcision technique plus SVF ... In terms of volume and area of scars, the mean percent change was 46.55 ± 13.92 and 44.60 ± 5.76, for the case group, and 13.31 ± 9.27 and 11.28 ± 9.64 for the control group, respectively. So, combine... According to the acquired results, combined therapy can be considered as effective and safe treatment for acne scars with significant higher efficacy compared with subcision alone....

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.

Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the on... ImmunoSep is a randomised placebo-controlled phase 2 clinical trial with a double-dummy design in which the effect of precision immunotherapy on sepsis phenotypes with MALS and immunoparalysis is stud... The protocol is approved by the German Federal Institute for Drugs and Medical Devices; the National Ethics Committee of Greece and by the National Organization for Medicines of Greece; the Central Co... NCT04990232....

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone p... In this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), a... Between Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (... In hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in simi... National Institute of Allergy and Infectious Diseases....

Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.

This study aimed to establish the 95% effective dose (ED95) of esketamine in combination with propofol for hysteroscopy and then to evaluate its efficacy and safety profile.... This prospective, double-blind, randomized controlled trial consisted of two cohorts. In cohort 1, 45 women aged 18-65 years undergoing hysteroscopy were randomly assigned to either group E (esketamin... The ED95 of esketamine was 0.254 mg/kg (95% CI: 0.214-1.004), while that of alfentanil was 9.121 μg/kg (95% CI: 8.479-13.364). The anesthesia success rate was 93.0% in group E and 95.2% in group A (p ... This study determined the ED 95 dose of esketamine for intravenous general anesthesia during hysteroscopy. Esketamine showed less respiratory and hemodynamic depression, as well as fewer adverse effec... www.chictr.org.cn, (ChiCTR2300077283); registered November 3, 2023....

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across... To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement.... The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The p... UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain... High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wile...

Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial).

To determine whether intravenous vitamin C compared with placebo, reduces vasopressor requirements in patients with vasoplegic shock.... Double-blinded, randomised clinical trial (RCT) conducted in two intensive care units in Perth, Australia. Vasopressor requirements at enrolment needed to be >10 μg/min noradrenaline after hypovolaemi... Of the 71 patients randomised (35 vitamin C, 36 placebo group), the median vasopressor duration was 44 h [95% CI, 37-54 h] and 55 h [95% CI, 33-66 h]) in the vitamin C and placebo groups (p = 0.057). ... In this RCT of patients with vasoplegic shock of at least moderate severity, the use of IV vitamin C compared with placebo did not significantly reduce the duration of vasopressors.... Prospective registration - trial number ACTRN12617001392358....

Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.

Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality. We sought to evaluate the safety and effect of pirfenidone on disease progression in such... We conducted a single-centre, randomised, double-blinded, placebo-controlled trial in adults with FHP and disease progression. Patients were assigned in a 2:1 ratio to receive either oral pirfenidone ... After randomising 40 patients, enrolment was interrupted by the COVID-19 pandemic. There was no significant between-group difference in FVC% at week 52 (mean difference -0.76%, 95% CI -6.34 to 4.82). ... The trial was underpowered to detect a difference in the primary end point. Pirfenidone was found to be safe and improved PFS in patients with FHP.... NCT02958917....

Comparison of intravenous ibuprofen and tenoxicam efficiency in ankle injury: a randomized, double-blind study.

Pain after soft tissue injuries in and around the ankle is a troublesome process in terms of patient comfort and mobilization. The aim of this study was to compare the analgesic efficacy of intravenou... We conducted a prospective, double-blind, randomized controlled study in a tertiary hospital. The patients were divided into two groups as those administered IV 400 mg ibuprofen and IV 20 mg tenoxicam... One hundred and twenty-four patients were included in the study. There were 62 patients in the tenoxicam group and 62 patients in the ibuprofen group. When VAS scores were compared, it was found that ...